These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3339614)

  • 1. (8 beta)-Ergoline-8-carboxylic acid cycloalkyl esters as serotonin antagonists: structure-activity study.
    Garbrecht WL; Marzoni G; Whitten KR; Cohen ML
    J Med Chem; 1988 Feb; 31(2):444-8. PubMed ID: 3339614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Methylergoline-8-carboxylic acid esters as serotonin antagonists: N1-substituent effects on 5HT2 receptor affinity.
    Marzoni G; Garbrecht WL; Fludzinski P; Cohen ML
    J Med Chem; 1987 Oct; 30(10):1823-6. PubMed ID: 3656357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (8 beta)-6-methylergoline amide derivatives as serotonin antagonists: N1-substituent effects on vascular 5HT2 receptor activity.
    Misner JW; Garbrecht WL; Marzoni G; Whitten KR; Cohen ML
    J Med Chem; 1990 Feb; 33(2):652-6. PubMed ID: 2299630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML; Parli CJ; Fuller RW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amesergide and structurally related nor-D-ergolines: 5HT2 receptor interactions in the rat.
    Martinelli MJ; Bloomquist W; Peterson BC; Cohen ML
    J Med Chem; 1993 Sep; 36(18):2671-5. PubMed ID: 8410979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
    McBride PA; Mann JJ; Nimchinsky E; Cohen ML
    Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.
    Pertz H; Eich E
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):394-401. PubMed ID: 1320207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LY53857, a selective 5HT2 receptor antagonist, on 5HT-induced increases in cutaneous vascular permeability in rats.
    Cohen ML; Schenck K
    Life Sci; 1989; 44(14):957-61. PubMed ID: 2927252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine, but not rat bladder contracts to serotonin via activation of 5HT2 receptors.
    Cohen ML
    J Urol; 1990 May; 143(5):1037-40. PubMed ID: 2139474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD; Shannon HE
    Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
    Perregaard J; Andersen K; Hyttel J; Sánchez C
    J Med Chem; 1992 Dec; 35(26):4813-22. PubMed ID: 1336053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
    Foreman MM; Fuller RW; Nelson DL; Calligaro DO; Kurz KD; Misner JW; Garbrecht WL; Parli CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):51-7. PubMed ID: 1731051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and serotonin 2 (5-HT2) receptor antagonist activity of 5-aminoalkyl-substituted pyrrolo[3,2-c]azepines and related compounds.
    Mizuno A; Ogata A; Kamei T; Shibata M; Shimamoto T; Hayashi Y; Nakanishi K; Takiguchi C; Oka N; Inomata N
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):623-35. PubMed ID: 10823697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R; Schäfer U; Ott T
    Arzneimittelforschung; 1992 Oct; 42(10):1175-9. PubMed ID: 1472137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-stimulated protein phosphorylation in aortic smooth muscle cells.
    Nakaki T; Wise BC; Chuang DM; Kato R
    Experientia; 1989 Sep; 45(9):879-81. PubMed ID: 2776859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.